Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06084897 | Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy | recruiting | Phase 2 | 120 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT03621982 | Study of ADCT-301 in Patients With Selected Advanced Solid Tumors | terminated | Phase 1 | 78 | ADC Therapeutics S.A.INDUSTRY | 3 | Jun 13, 2024 | clinicaltrials |
| NCT05471401 | GI Organ Tracking Via Balloon Applicators | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Jun 13, 2024 | clinicaltrials |
| NCT05553795 | Drainless Robot-assisted Minimally Invasive Esophagectomy(RESPECT) | terminated | N/A | 49 | Technische Universität DresdenOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06342167 | Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | active not recruiting | Phase 2 | 57 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT03840967 | A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma | terminated | Phase 2 | 14 | Shadia Jalal, MDOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06429839 | Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients | recruiting | Phase 2 | 55 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT06429865 | Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma | unknown | N/A | 1,000 | Changhai HospitalOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT06431100 | a Single-arm, Single-center, Open Clinical Study(GK-01) | recruiting | — | 10 | Beijing Geekgene Technology Co., LTDINDUSTRY | 1 | May 28, 2024 | clinicaltrials |
| NCT06314516 | Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes(INSPECT) | completed | — | 1,717 | Benaroya Research InstituteOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03306901 | Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma(ASSURE) | active not recruiting | N/A | 240 | Samsung Medical CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06426797 | Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma | not yet recruiting | Phase 2 | 25 | Peking University People's HospitalOTHER | 0 | May 23, 2024 | clinicaltrials |
| NCT06424210 | The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1) | completed | — | 163 | National Taiwan University HospitalOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05490719 | A Phase II Study of CRT Combined With QL1706 in ESCC Patients | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06408584 | Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab(SCHRT) | recruiting | — | 25 | Anhui Provincial HospitalOTHER_GOV | 1 | May 21, 2024 | clinicaltrials |
| NCT06418516 | Early Detection of Esophageal Squamous Cancer With the Capsule Sponge Device(ANGELA) | not yet recruiting | N/A | 340 | Centre of Postgraduate Medical EducationOTHER | 0 | May 17, 2024 | clinicaltrials |
| NCT06419244 | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04207918 | A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer | completed | Phase 2 | 55 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06410651 | Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma | recruiting | Phase 2 | 53 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06410677 | Changhai Multimodal Esophageal Cancer Cohort(CMECC) | unknown | — | 110 | WangluoweiOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06381583 | A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma(EMERALD) | completed | — | 658 | City of Hope Medical CenterOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT04159974 | RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus(RICE) | unknown | Phase 2 | 56 | University of CologneOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT02509286 | Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus(ESOPEC) | unknown | Phase 3 | 438 | University Hospital Schleswig-HolsteinOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT03243734 | trūFreeze® Palliative Esophageal Cancer | completed | N/A | 49 | US Endoscopy Group Inc.INDUSTRY | 1 | May 8, 2024 | clinicaltrials |
| NCT04192695 | Esophageal Squamous Cell Cancer Surveillance With Cytosponge | completed | N/A | 178 | Centre of Postgraduate Medical EducationOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06403878 | Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer | unknown | Phase 2 | 68 | Sichuan UniversityOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05523960 | Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery | completed | N/A | 652 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT06398405 | A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer | unknown | Phase 2 | 72 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03165994 | APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers | completed | Phase 2 | 34 | Apexigen America, Inc.INDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT06190782 | Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor | recruiting | Phase 3 | 354 | Fudan UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06392971 | Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis | unknown | Phase 2 | 120 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06252974 | Accurate Diagnosis of the Invasion Depth in ESCC by a Deep Neural Network Analysis of NBI Endoscopy Data | unknown | — | 500 | RenJi HospitalOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT06388135 | Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma | not yet recruiting | Phase 4 | 80 | Yang Jianjun, PhDOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT03468634 | Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy(RaPIDE) | completed | N/A | 25 | University of ExeterOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06361043 | Conebeam CT-based Online Adaptive Radio-Therapy for Esophageal Cancer (ARTEC)(ARTEC) | recruiting | — | 30 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT05056051 | Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus | unknown | N/A | 200 | Northwestern UniversityOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05082948 | Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement | completed | N/A | 46 | West Virginia UniversityOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT02129933 | VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions(VICE) | completed | Phase 1 | 14 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03205501 | Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions(EAGLE) | completed | Phase 1 | 15 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03558724 | Fluorescence Endoscopy of Esophageal Carcinoma(ORCA) | terminated | Phase 1 | 25 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04656392 | Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary Care(ELECTRONIC) | completed | N/A | 449 | Radboud University Medical CenterOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06366685 | Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After Esophagectomy(Recovery) | unknown | N/A | 60 | Mengmeng YuanOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04272268 | Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications(Hi-FLO) | withdrawn | — | 0 | University Hospitals of North Midlands NHS TrustOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06354218 | Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age | recruiting | Phase 2 | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06354530 | A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma | recruiting | Phase 2 / Phase 3 | 266 | Army Medical Center of PLAOTHER_GOV | 1 | Apr 9, 2024 | clinicaltrials |
| NCT03060642 | The Microenvironment in Barrett's Esophagus(BETRNet2) | completed | — | 155 | Columbia UniversityOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT04896242 | Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients | completed | — | 47 | Pontificia Universidad Catolica de ChileOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT05314946 | Nutritional Support During Induction Therapy for Esophageal Cancer | unknown | N/A | 26 | Mehdi QiabiOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Jun 14, 2024source: clinicaltrials